4.7 Article

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Related references

Note: Only part of the references are listed.
Article Immunology

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Chanu Rhee et al.

Summary: SARS-CoV-2 is most contagious around symptom onset, with infectivity rapidly decreasing to near-zero afterwards; mild-moderately ill patients can safely discontinue isolation after about 10 days, while severely-critically ill and immunocompromised patients may need 15 days. The longest duration associated with replication-competent virus is 20 days.

CLINICAL INFECTIOUS DISEASES (2021)

Editorial Material Immunology

Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child

Casper K. Lumby et al.

CLINICAL INFECTIOUS DISEASES (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report

G. F. Deen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Virology

Within host RNA virus persistence: mechanisms and consequences

Richard E. Randall et al.

CURRENT OPINION IN VIROLOGY (2017)

Article Medicine, General & Internal

Late Ebola virus relapse causing meningoencephalitis: a case report

Michael Jacobs et al.

LANCET (2016)

Article Virology

Within-Host Evolution Results in Antigenically Distinct GII.4 Noroviruses

Kari Debbink et al.

JOURNAL OF VIROLOGY (2014)

Article Medicine, General & Internal

Vaccine-Derived Poliomyelitis 12 Years after Infection in Minnesota

Aaron S. DeVries et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)